Inhibition of cytochrome P-450-linked monooxygenase systems by naphthoquinones.
Several naphthoquinones, except 2-hydroxy-1,4-naphthoquinone, were found to inhibit microsomal cytochrome P-450-linked monooxygenase activities in rabbit liver and human placenta. In particular, 5-hydroxy-1,4-naphthoquinone inhibited placental estrogen biosynthesis more effectively than it did hepatic drug oxidation reactions. There was little contribution by superoxide radicals to these enzyme inhibitions by naphthoquinones. Spectrophotometric studies revealed that naphthoquinones bind to the cytochrome P-450 component of the monooxygenase complex in both microsomal systems, suggesting that the inhibition is caused by direct interaction of these compounds with the heme.
D000735:Androstenedione / Q000378:metabolism; D000818:Animals; D003577:Cytochrome P-450 Enzyme System; D003574:Cytochrome c Group / Q000378:metabolism; D006801:Humans; D008861:Microsomes / Q000201:enzymology; D008862:Microsomes, Liver / Q000201:enzymology; D009285:Naphthoquinones / Q000494:pharmacology*; D010105:Oxygenases / Q000037:antagonists & inhibitors*; D010920:Placenta / Q000201:enzymology; D011817:Rabbits; D013053:Spectrophotometry; D014812:Vitamin K / Q000494:pharmacology
D003574:Cytochrome c Group; D009285:Naphthoquinones; D014812:Vitamin K; D000735:Androstenedione; D003577:Cytochrome P-450 Enzyme System; D010105:Oxygenases; C005134:juglone; C014758:plumbagin